Dr. Premranjan Singh specializes in Cardiovascular disease and practices Ocala, FL and 1 more location. Dr. Singh is affiliated with Munroe HMA Hospital LLC, Ocallaghan Regional Medical Center and West Marion Community Hospital. He has won a number of awards to his credit and has published more than 20 articles in this field.Â
EDUCATION
- Interventional Cardiology Fellowship Lahey Clinic, Burlington, MA
- Cardiovascular Disease Fellowship, Lahey Clinic, Burlington, MA
- Research Fellowship, Department of Cardiology, Lahey Clinic, MA
- Residency Internal Medicine, University of Illinois College of Medicine, IL
EXPERIENCE
- Staff Physician, Cardiology, Interventional Cardiology, Vascular medicine and Internal Medicine at Monroe Regional Medical Center, Ocala Régional Medical Center  and West Marion Cumunity Hospital. Ocala, FL
- CVI (Private Practice) Interventional cardiology/Vascular Medicine / Cardiology / Internal Medicine, Â Ocala, FL
- Urban Cardiology (Privat practice) Interventional cardiology/Vascular Medicine / Cardiology / Internal Medicine, Â Ocala, FL
- Marion Heart Associate  (Private Practice) Interventional Cardiology/Vascular Medicine / Cardiology/ Internal Medicine, Ocala, FL
CERTIFICATIONS
- Interventional Cardiology Board Certification (ABIM)
- Cardiology Board Certification (ABIM)
- Certification Board of Echocardiography (ASE)
- Certification American Board of Vascular Medicine (ABVM)
- Certification American Board of Vascular Medicine (Endovascular)
- Florida Medical License
- Certification Board of Nuclear Cardiology (CBNC)
- American Board of Internal Medicine (ABIM) Certification
- ECFMG Certification
AWARDS
- Chair, Peripheral Arterial Disease (PAD) writing group, Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D)
- Member, Symptom Writing group, Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D)Â
- Society for Cardiac Angiography and Interventions (SCAI)
- Member, American College of Cardiology (ACC)
- Member, American Heart Association
- Member, American College of Physicians
- Member, American Medical Association
- Member, Red Cross Society 1999 - MD with HONORS, P.M.C.H.
- Dean List, Medical College.
PUBLICATIONS
- Abbott JD, Lombardero MS, Barsness GW, Singh PP, Woodhead G, Kelsey SF. Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Am Heart J. 2012 Oct;164(4):585-590.e4. doi: 10.1016/j.ahj.2012.06.017. PMID: 23067918 Â
- Singh PP, Abbott JD, Lombardero MS, Piemonte TC, Lago RM, Rutter MK, Nesto RW; Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Diabetes Care. 2011 Feb;34(2):464-7 Â
- BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, Sobel BE. A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med. 2009 Jun 11;360(24):2503-15. Epub 2009 Jun 7. PMID: 19502645 [PubMed - indexed for MEDLINE] Â
- Pop-Busui R, Lu J, Lopes N, Jones TL; BARI 2D Investigators. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.,J Peripher Nerv Syst. 2009 Mar;14(1):1-13. PMID: 19335534 Â
- Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Am Heart J. 2008 Sep;156(3):528-536, 536.e1-5. Epub 2008 Jul 31.PMID: 18760137 Â
- Vidi V, Rajesh V, Singh PP, Mukherjee JT, Lago RM, Waxman S, Nesto RW: Clinical characteristics of tako-tsubo cardiomyopathy Am J Cardiol. 2009 Aug 15; 104(4):578-82. Epub 2009 Jun 18 Â Â
- Vidi V, Singh PP, Alhumaid AC, Lee RS, Kinnunen PM: Hydropneumopericardium presenting as an acute coronary syndrome: a rare complication of paraesophageal hernia, Tex Heart Inst J. 2009;36(3):255-8. Â
- Singh PP, Lago RM, Nesto RW: Myocardial Glucose Transport and Utilization: A Target for Therapeutic Intervention Rev Cardiovasc Med. 2008; 9(2)
- Lago RM, Singh PP, Nesto RW: Â Obesity, Type 2 Diabetes, and Cardiovascular Disease: Â CME, Baylor college of Medicine Reports on Cardiometabolic Disorders, Vol 2, Number1, www.lipidsonline.org Â
- Vidi V, Singh PP, Nesto PP: Tako-tsubo syndrome following a difficult urinary catheterization, Int J Cardiol. 2008 Jun 3. Â
- Ishibashi F, Mizuno K, Singh PP, Nesto PP, Waxman S: High Yellow Color Intensity by Angioscopy With Quantitative Colorimetry to Identify High-Risk Features in Culprit Lesions of Patients With Acute Coronary Syndromes ? ?American Journal of Cardiology ?15 October 2007 Vol. 100, Issue 8, Pages 1207-1211. Â
- Lago RM, Singh PP, Nesto RW: Diabetes and hypertension.: Nat Clin Pract Endocrinol Metab. 2007 Oct ;3 (10):667 Â Â
- Lago RM, Singh PP, Nesto RW: Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomized clinical trials. Lancet. 2007 Sep 29;370 (9593):1129-36 Â Â
- Singh PP, Lago RM, Nesto RW: Do nondiabetic patients with acute coronary syndromes and hyperglycemia benefit from insulin therapy? Nat Clin Pract Cardiovasc Med. 2008 Mar 18; Â 18349825
- Nesto RW, Singh PP: Diabetes and residual risk of coronary heart disease. Nature Clin Pract Endocrinol Metab. 2007 Feb;3(2):71.Â
- Singh PP, Nesto RW, Faxon DP, Lepor NE, Watson KE, Jacobs AK, McCullough PA. Best of the AHA Scientific Sessions 2006.Rev Cardiovasc Med. 2007 Winter;8(1): 25-35
- Singh PP, Nesto RW, Myocardial Glucose transport and utilization: A Target For Therapeutic Intervention. Rev Cardiovasc Med. 2007 (In Press) Â
- Singh PP, Rutter MK, Lombardero MS, Piemonte TC, Nesto RW: Prevalence and Clinical Predictors of High Ankle Brachial Index in Patients with Type 2 Diabetes and CHD in the BARI-2D Trial. Abstract/Poster presentation ADA Chicago 2007. Â
- Woodhead GA, Massaro EM, Lombardero M, Singh PP: Significance of Measuring Ankle-Brachial Index in the Type 2 Diabetic Patients with Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial. [BARI 2D] abstract Vascular Nursing Meeting  Maryland 2007.
- Singh PP, Abbott DJ, Lombardero MS, Piemonte TC, Nesto RW: Prevalence and Clinical Characteristics of Peripheral Artery Disease in Patients with Type 2 Diabetes and CAD Enrolled in The BARI 2D Trial. Abstract/Poster presentation AHA Chicago 2006
- Ishibashi F, Mizuno K, Kawamura A, Singh PP, Waxman S.: Frequency of non-culprit thin –cap lipid cores in myocardial infarction and stable angina. Abstract SCAI 2006
- Singh PP, Kocheril A; Use of IV Nesiritide in End Stage Renal Disease and Heart Failure. A Poster Presentation to ACP Illinois chapter 2003.Â